The effect of acute and repeated administration of buspirone, 8-OHDPAT and fluoxetine on haloperidol-induced extrapyramidal symptoms.
The aim of this study was to investigate the effect of buspirone, as a partial agonist of 5-HT₁A receptors, 8-hydroxy-2-[di-n-propylamino]-tetralin (8-OH-DPAT) as an agonist of 5-HT₁A receptors and fluoxetine as a selective serotonin reuptake inhibitor on haloperidol-induced extrapyramidal symptoms (EPS) in male Wistar rats. The experiments were performed on 66 male Wistar rats weighing 200-240g. The rats were divided into 11 groups (n=6). Extrapyramidal symptoms were induced by haloperidol injection 1mg/kg intraperitoneally (i.p.). To investigate the effect of serotonergic drugs on haloperidol-induced extrapyramidal symptoms, 8-OHDPAT (1 mg/kg), buspirone (10 mg/kg), and fluoxetine (1 mg/kg) were injected before haloperidol in an acute and 7 consecutive day's pre-treatment injection(s) mode. Extrapyramidal symptoms such as catalepsy and motor balance were assessed by the bar test and rotarod, respectively. The results demonstrated that i.p. injection of haloperidol induced significant motor imbalance and catalepsy (p≤0.001) in rats. Data analysis showed that i.p. injection of buspirone (10 mg/kg) significantly decreased catalepsy compared with the control group. The attenuation of haloperidol-induced extrapyramidal symptoms was observed with 8-OHDPAT treatment. Treatment with fluoxetine did not affect the motor coordination caused by haloperidol. It may be concluded that buspirone and 8-OHDPAT improves extrapyramidal symptoms in a haloperidol-induced Parkinsonism model probably via activation of 5-HT₁A receptors. However, further investigations should be carried out to clarify the exact mechanism of interaction between 5-HT₁A and DA receptors.